JP2015513521A5 - - Google Patents

Download PDF

Info

Publication number
JP2015513521A5
JP2015513521A5 JP2014543711A JP2014543711A JP2015513521A5 JP 2015513521 A5 JP2015513521 A5 JP 2015513521A5 JP 2014543711 A JP2014543711 A JP 2014543711A JP 2014543711 A JP2014543711 A JP 2014543711A JP 2015513521 A5 JP2015513521 A5 JP 2015513521A5
Authority
JP
Japan
Prior art keywords
group
carbon atoms
alkyl
disorder
depression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014543711A
Other languages
English (en)
Japanese (ja)
Other versions
JP6415982B2 (ja
JP2015513521A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014543711A priority Critical patent/JP6415982B2/ja
Priority claimed from PCT/JP2013/057923 external-priority patent/WO2013137479A1/en
Publication of JP2015513521A publication Critical patent/JP2015513521A/ja
Publication of JP2015513521A5 publication Critical patent/JP2015513521A5/ja
Application granted granted Critical
Publication of JP6415982B2 publication Critical patent/JP6415982B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014543711A 2012-03-12 2013-03-11 複素環化合物 Active JP6415982B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014543711A JP6415982B2 (ja) 2012-03-12 2013-03-11 複素環化合物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012054467 2012-03-12
JP2012054467 2012-03-12
PCT/JP2013/057923 WO2013137479A1 (en) 2012-03-12 2013-03-11 Decahydroquinoxaline derivatives and analogs thereof
JP2014543711A JP6415982B2 (ja) 2012-03-12 2013-03-11 複素環化合物

Publications (3)

Publication Number Publication Date
JP2015513521A JP2015513521A (ja) 2015-05-14
JP2015513521A5 true JP2015513521A5 (cg-RX-API-DMAC7.html) 2016-04-21
JP6415982B2 JP6415982B2 (ja) 2018-10-31

Family

ID=48048149

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014543711A Active JP6415982B2 (ja) 2012-03-12 2013-03-11 複素環化合物

Country Status (4)

Country Link
JP (1) JP6415982B2 (cg-RX-API-DMAC7.html)
AR (1) AR090312A1 (cg-RX-API-DMAC7.html)
TW (1) TW201348215A (cg-RX-API-DMAC7.html)
WO (1) WO2013137479A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150368213A1 (en) * 2014-06-20 2015-12-24 The University of Montana, Missoula, MT Novel Inhibitors of System Xc-
AU2022312844A1 (en) * 2021-07-13 2024-01-04 Otsuka Pharmaceutical Co., Ltd. Hydrogenated quinoxalines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210941A1 (de) * 1992-04-02 1993-10-07 Bayer Ag Neue 9-Fluor-7.oxo-7H-pyrido[1,2,3-d,e][1,4]benzoxacin-6-carbonsäuren und -ester
ES2226284T3 (es) * 1998-04-16 2005-03-16 Pfizer Products Inc. N-acil y n-aroil-aralquilamidas.
IT1312310B1 (it) * 1999-05-07 2002-04-15 Recordati Ind Chimica E Farma Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
BRPI0507190A (pt) * 2004-01-29 2007-06-26 Pfizer Prod Inc combinação de moduladores do ácido gama-aminobutìrico e antagonistas de 5-ht1b receptores
CN101528225B (zh) * 2006-08-07 2013-07-17 阿尔巴尼分子研究公司 作为5ht3调节剂的2-氨基苯并噁唑羧酰胺
JP2012528871A (ja) * 2009-06-03 2012-11-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー メラニン凝集ホルモン受容体1アンタゴニストとしてのビス−ピリジルピリドン類
WO2011068171A1 (ja) * 2009-12-03 2011-06-09 第一三共株式会社 二環性含窒素飽和へテロ環誘導体
EA024099B1 (ru) * 2010-09-13 2016-08-31 Оцука Фармасьютикал Ко., Лтд. Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина

Similar Documents

Publication Publication Date Title
AU2010339423B9 (en) Therapeutic compounds and related methods of use
JP2022153616A (ja) Shp2阻害剤として有用な新規複素環式誘導体
CA2968242C (en) 4-oxo-3,4-dihydro-1,2,3-benzotriazines as modulators of gpr139
TW200526604A (en) Methods for synthesizing quinolinone compounds
CN105473573B (zh) 用作激酶抑制剂的咔唑甲酰胺化合物
EP2726485A1 (en) Quinazolines as therapeutic compounds and related methods of use
AU2015335783B2 (en) Tricyclic atropisomer compounds
CN110267945A (zh) 氰基取代的吲哚化合物及其作为lsd1抑制剂的用途
US20170342054A1 (en) Compounds and methods of use thereof
CA2651363A1 (en) Triazolopyrazine derivatives useful as anti-cancer agents
JP2005521698A (ja) 新規な三環式化合物
HUP0301932A2 (hu) IL-1béta és TNF-a inhibitor benzofenon származékok, ezeket tartalmazó gyógyszerkészítmények és ezek alkalmazása gyógyszerkészítmények elżállítására
JPWO2020017587A5 (cg-RX-API-DMAC7.html)
TW200914431A (en) Novel morpholine compounds
TW200916458A (en) Heterocyclic compounds and methods of use thereof
JP2020511515A5 (cg-RX-API-DMAC7.html)
JP2017517538A (ja) Gabaa受容体活性のモジュレーターとしてのイミダゾピリダジン誘導体
TW201536774A (zh) 經取代之四氫咔唑及咔唑甲醯胺化合物
JP2019535825A5 (cg-RX-API-DMAC7.html)
JP2007500168A5 (cg-RX-API-DMAC7.html)
CN105722840A (zh) 作为PI3K、mTOR抑制剂的稠合喹啉化合物
HRP20151282T1 (hr) Heterocikliäśki spojevi za lijeäśenje ili prevenciju bolesti izazvanih smanjenom neurotransmisijom serotonina, norepinefrina ili dopamina
EP1987007A1 (en) 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases
JP2005538974A5 (cg-RX-API-DMAC7.html)
JP2006511498A5 (cg-RX-API-DMAC7.html)